Table: begin end state 1 26 signal peptide 27 40 non-cytoplasmic 41 59 transmembrane 60 79 cytoplasmic 80 100 transmembrane 101 131 non-cytoplasmic 132 152 transmembrane 153 178 cytoplasmic 179 204 transmembrane 205 216 non-cytoplasmic 217 238 transmembrane 239 250 cytoplasmic 251 271 transmembrane 272 305 non-cytoplasmic 306 324 transmembrane 325 334 cytoplasmic 335 359 transmembrane 360 391 non-cytoplasmic 392 418 transmembrane 419 433 cytoplasmic 434 456 transmembrane 457 461 non-cytoplasmic 462 482 transmembrane 483 525 cytoplasmic
Input: >WP_057509185.1 NCBI__GCF_001431535.1:WP_057509185.1 MVFRISIALVAVLVLLAGLAPDAFNSVVQTVLAEVVRGAGWLYLLVVFLALSFLLYLAFG RFANLRIGGEDAEPDFSRASWMSMLFAAGMGIGLVFWGAAEPVSHFVKPPEGLEPMGMEA ARASMRYAFFHWGLHPWAIYALIGLAMAWFQFNRNGRGLVSDMLQPIIGHHHRGWIGQVV NIAAVVATAIGVATTLGFGTIQIAAGLERVFGIPSNVPTQMVIIAVAFVLYMASTMSGVD RGIKWLSNFNLGLAALLLAMVLVLGPTGFIFDTFTTTLGSYLNQLVTMSLRMSPFSGSTW VVDWTIFYWAWWIAWAPFVGAFIARISRGRSVREFVVGVVIAPTVLGFIWFSVFGGTALW SQIFGHVDLVAALGNGYETVLFTMFDSLPLPLVLASVALVLLMIFFVTSADSAVLVLASM STDEAGDPPLKRKVAWGVAIALIAAALLLAGGLAALQGMITIAALPFALLMILVMVSLYR VLDQEWTRERRKAQRARQMIESWIEREMAAQEETRQEAGRAAERD
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server